作者： admin

　　On December 25th, Mazda6 2011 was officially listed in Shenzhen Zhongshenlian Mazda, with a price of 157,800-169,800 yuan.

　

Opening performance

　　 The 2011 model is the latest Mazda model, which is more dynamic, more fashionable and more maneuverable, perfectly interpreting the Mazda brand.ZOOM-ZOOM"The sportsmanship. A related person from FAW Mazda said that it is more fashionable, more sporty, more interesting to drive and faster to beat the heart. This is Mazda6 2011.

Speech by General Manager Shao of Shenzhen Zhongshen Lian

　　With the products coming to the store one after another, Mazda6 2011 set off a new wave of Mazda in the store. The extremely dynamic coupe style and shape, the fashion charm of the same strain, and the control strength of the "King of Curves" made Mazda6 2011 quickly become the new focus of Shenzhen auto market, thus starting the first shot of the auto market at the end of the year.

General Manager Shao of Zhongshen Lianlian and Manager Hu of Sales Department unveiled the new car.

　　　The relevant person in charge of FAW Mazda said that Mazda6 2011 is worth the money and will surely become one of the best B-class car choices for consumers.

　

Live lottery

Coupe style, leading the new fashion

　　Mazda6 2011 embodies Mazda’s consistent fashion modeling concept, and highlights the extreme sports style, as well as the extremely sporty tension and fashion charm. The sharp and elegant appearance is the outstanding feature of Mazda6 2011, which looks like the classic coupe of Mazda6.

　　Mazda6 2011 adopts bright silver bar grille as the front face shape, and adopts ten-spoke wheel tires, which reflects the sports style and design concept of the coupe. At the same time, the headlights and fog lamps with distinct three-dimensional and layered sense make Mazda6 2011 look dynamic and steady.

Play the Violin

　　The manager of FAW Mazda XX dealership stressed to the reporter that "Mazda6 has always been synonymous with fashion and dynamic, and falling in love at first sight and dynamic fashion is the overall feeling of Mazda6 2011, which reflects Mazda’s consistent sportsmanship and charm".

Manager Hu of the sales department gives the car keys to the new owner.

King of corners, control is more powerful.

　　For Mazda6, maneuverability is the innate DNA, and Mazda6 2011 perfectly inherits the reputation of "the king of curves". In terms of suspension, the front suspension adopts high-position double wishbone independent front suspension, and the rear suspension adopts multi-link independent suspension. The suspension adjustment is flexible and sporty, and the load distribution between the front and rear wheels is close to 50: 50, which makes Mazda6 2011 model have excellent cornering ability.

Award-winning riders receive awards

　　In terms of power, the 2011 Mazda performed equally well. Mazda6 2011 matching MZR2.0 engine is a mature and stable engine with strong power, ultra-low fuel consumption, with a maximum output of 108 kW and a maximum torque of 183 N/m.

Car lottery

　　Mazda6 2011 is equipped with a sensitive 5-speed manual/automatic transmission and a 6-speed manual transmission, with a maximum safe speed of 211km/h and an acceleration time of 9.7s for 0-100km. It is a rare 10second club member among mid-to high-end cars.

　　In addition, Mazda6 2011 engine applies advanced technologies such as S-VT, VIS, VTCS and VAD. By improving the intake system and timing system, the power output of the engine is more efficient, more uniform and stronger, which greatly meets the driving needs of the whole vehicle at low speed, medium speed and high speed.

Low fuel consumption and high safety.

Draw the first prize on the spot

　　In terms of fuel consumption, Mazda6 2011 stands out among all cars. Authoritative evaluation from China Automobile Industry Association shows that Mazda6 2.0L has the lowest fuel consumption in the same car, and the actual comprehensive fuel consumption of 2.0L automatic transmission is 7.97 liters/100 kilometers, while the actual comprehensive fuel consumption of 2.0L manual transmission is as low as 7.8 liters/100 kilometers.

　　In terms of safety, the performance of Mazda6 2011 is even better. In terms of active safety, Mazda6 2011 has a braking distance of 37 meters and complete high-tech electronic equipment, making driving safe and worry-free. In terms of passive safety, Mazda6 2011 has a unique 3-hour high-rigidity body, 6 airbags, anti-intrusion brake pedals, etc., and is fully equipped.

　

The first prize won the warm and cold box

　　According to industry experts’ analysis, the aesthetic feeling and handling strength of Mazda6 2011 are the soul signs of Mazda6 series models, which will surely become the key to its rapid market win.

　　From the aspects of appearance, performance and cost performance, Mazda6 2011 is still one of the most competitive models in the mid-level car camp, which raises the feeling of value for money to a new height and will become the best B-class car choice for consumers. This is also the mission of the 2011 Mazda6!　

Dealer: Shenzhen Zhongshenlian Automobile Trading Co., Ltd.

Address: A8-A9 Dongyi Automobile Plaza, Yanfang Road, Luohu District, Shenzhen

Sales hotline: 0755-25116288/13632998882

Xinhua News Agency, Beijing, February 15th Title: Let more life-saving and emergency-saving drugs enter medical insurance-The construction of dynamic adjustment mechanism of medical insurance catalogue in China has entered an accelerated period.

Xinhua News Agency reporter Chen Fang, Zhang Quan

The change of medical insurance catalogue is related to the well-being of hundreds of millions of participants.

Zero tariff on imported anticancer drugs, medical insurance negotiation, centralized drug procurement organized by the state … Since 2018, China has taken a series of measures to promote drug price reduction.

The executive meeting of the State Council recently pointed out that China will speed up the frequency of adjusting the medical insurance drug list and include more life-saving anticancer drugs and other drugs into medical insurance. This means that the construction of the dynamic adjustment mechanism of China’s medical insurance catalogue has entered an accelerated period, and the people are expected to gain more happiness.

Anti-cancer drugs enter medical insurance, and patients no longer look forward to "drugs"

The movie Dying to Survive, which was a big hit last year, aroused widespread concern about anticancer drugs in society. Once, "a pill" dragged down a family. Now, anticancer drugs have entered medical insurance, bringing hope to more families.

With the comprehensive promotion of medical reform, the "combination boxing" of drug price reduction policy has been implemented one after another and achieved practical results. Accelerating the adjustment frequency of medical insurance drug list and bringing more good drugs into medical insurance have become the key links to benefit patients.

For lung cancer patients with T790M gene mutation, the third-generation targeted drug oxitinib has obvious curative effect, but for Mr. Wang of Anhui Province, the "sky-high price" of a box of 50,000 yuan once made him look forward to "medicine". After the national medical insurance negotiation and inclusion in medical insurance, the burden of medical expenses has been greatly reduced.

The relevant person in charge of the National Medical Insurance Bureau said that in order to allow patients to enjoy more good drugs without causing a serious deficit in the medical insurance fund, China has reduced the drug price through price negotiation and squeezed out the unreasonable part of the drug price.

In October 2018, 17 kinds of anticancer drugs, including oxitinib, were included in the Category B scope of the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2017 Edition), and the medical insurance payment standard decreased by an average of 56.7% compared with the retail price.

By the end of last year, medical institutions and pharmacies nationwide had purchased about 1.84 million tablets (tablets/unit) of 17 kinds of anticancer drugs negotiated by the country at the negotiated price, with a total purchase amount of 562 million yuan, which saved 918 million yuan in procurement costs compared with the pre-negotiated price, and reduced the cost burden after medical insurance reimbursement by more than 75%.

To meet the people’s drug demand, the national medical insurance drug list "grows again and again"

Since the first edition of the national medical insurance drug list was formulated in 2000, it has been revised in 2004, 2009 and 2017, and the coverage of drugs has been increasing. When the 2017 edition of the National Medical Insurance Catalogue was released, it contained a total of 2,535 drugs. During the revision process, four types of clinical drugs, such as children’s drugs, innovative drugs, major disease treatment drugs and ethnic drugs, were given key support.

The incidence of chronic diseases and malignant tumors has increased, and the number of patients with rare diseases has continued to increase … At present, the spectrum of diseases in China’s population has changed significantly. Compared with the drug demand of the masses, there is still much room for improvement in the updating frequency, catalogue proportion and structure of the national medical insurance catalogue. For example, in 2018, the first batch of 121 rare diseases listed by the state that patients in urgent need of treatment drugs have not been included in medical insurance; Hummel, the "global drug king" who has 17 indications and treats a variety of rheumatic immune diseases, is also out of the catalogue.

In May last year, China published the First List of Rare Diseases, in which 121 rare diseases such as multiple sclerosis were included. In July, National Medical Products Administration approved the marketing of Obadiah in China for the treatment of relapsing multiple sclerosis, which is the first oral disease correction drug approved in China for the treatment of multiple sclerosis.

"No matter whether it is a rare disease or a chronic disease, a disease that causes a huge economic burden to patients is a serious illness." Wang Chen, an academician of China Academy of Engineering and director of Peking Union Medical College of China Academy of Medical Sciences, said that biological agents are the most effective drug for treating some chronic diseases at present. If patients can get timely and standardized treatment, they will maximize their quality of life. We should use the medical insurance mechanism to assume the social responsibility of benefiting more patients, give full play to the scientific guiding role of the medical insurance mechanism in the medical ecology of the whole society, encourage the research and development of drugs for the treatment of rare diseases, and make the basic drug list and the basic medical insurance list and other related systems reasonably connected and linked.

Dynamic adjustment mechanism is the key to let more good drugs enter medical insurance.

The Central Economic Work Conference held not long ago clearly stated that "more life-saving and emergency-saving medicines should be included in medical insurance". The the State Council executive meeting held on February 11th once again proposed to speed up the registration and approval of new anticancer drugs at home and abroad, organize experts to select new overseas drugs that are urgently needed in clinic, improve the import policy, and promote the simultaneous listing of new overseas drugs in China. Smooth the temporary import channels of anticancer drugs urgently needed in clinic.

"For the people, this is a great benefit." Wang Bo, a special researcher at the National Center for Drug Policy and Pharmaceutical Industry Economics of China Pharmaceutical University, said that the most important thing now is to explore and establish a dynamic adjustment mechanism. It is necessary to strengthen the evaluation method of pharmacoeconomics, realize the selection method of combining clinical recommendation, industry association and enterprise application, and narrow the gap between people’s growing health demand and medical service supply level as soon as possible.

As a local innovative practice, medical insurance in some provinces and cities has included new drugs and good drugs which are urgently needed by patients, greatly improve the quality of life of patients and their families, have clear curative effects and are clinically necessary, and achieved good benefits. For example, Xiumeile, which is used to treat autoimmune diseases such as rheumatoid arthritis and ankylosing spondylitis, has been included in the serious illness medical insurance system of eight provinces, cities or units such as Qingdao, Shandong and Shenzhen, Guangdong in China.

Wang Bo believes that the country urgently needs to establish a mechanism of "making medicines well and getting good results". In the future, the coverage of the national medical insurance catalogue should be further expanded to more fields, so as to realize "regular approval of enterprises, regular review of medical insurance and regular update to meet the requirements". With the steady progress of a series of measures such as encouraging the research and development of innovative drugs and facilitating the listing of new drugs, more life-saving and emergency-saving good drugs can be accelerated.

By December 10, 2018, National Medical Products Administration Drug Evaluation Center had received and processed more than 1,500 applications for communication and exchange, including more than 600 applications for anti-tumor drugs, and the progress of innovative drug research and development of domestic pharmaceutical companies entered the expressway.

This year, China will cancel the declaration requirement that some imported drugs must be listed overseas before they can apply for import, encourage global innovative drugs to be developed simultaneously at home and abroad, and attract more cancer treatment drugs to be listed in China. While improving the quality of drugs and reducing the price of drugs, we will guide enterprises to increase innovation.

　

Lead: It is mentioned that you may think of domineering and hard-core ones, and the discovery series was also the talk of off-road veterans in the past. However, today we don’t talk about, defend, and discover that the price reduction is very severe.

Who would have thought that Land Rover, which you couldn’t afford in the past, can now be bought at the price of an ordinary joint venture SUV, and how much is it-209,800? Yes, you heard it right. From 209,800, I bought Land Rover, although I found the sports version.

You know, it is found that although the sports version is the cheapest model of Land Rover at present, its guide price also needs 359,800-446,600 yuan, and it is also a 350,000+class model.

However, with the 350,000 Discovery Sport Edition, how can consumers be willing to pay the bill in today’s automobile market? After all, today, more than 300 million people can buy better models, such as the ideal L series for family attributes, the 400 and Series for hardliners, the luxury style and so on.

The Discovery Sports Edition, which was sold in the early 200,000 s, is much cheaper. Compared with the guide price, the discount is as high as 150,000 (entry version), and the top discount is as high as 192,000 yuan.

But, even at this price, will it make your heart beat today?

Found the sports version, positioned in a medium-sized SUV, but its body length is only 4597mm, strictly speaking, it is not a standard medium-sized SUV. But then again, Land Rover’s design still gives the discovery of the sports version a good atmosphere, leaving aside the captain to make it look like a medium-sized SUV.

In addition, unexpectedly, this medium-sized SUV with a 4-level conductor also provides a 7-seat layout other than 5 seats. Presumably, after three rows of people are filled, the space experience will not be too plentiful.

It is found that the sports version is equipped with 2.0T, and the transmission is matched with 9AT gearbox. From the book configuration, there is nothing wrong with it, but according to the feedback from colleagues who have tested it, the matching of this system is not very good, and occasionally it can be obviously felt that there is frustration; Perhaps Land Rover should follow the pace and use ZF 8AT in this car. Maybe the driving experience will be better.

It is found that there is nothing wrong with the four-wheel drive in the sports version, and the suspension is equipped with the front McPherson+rear multi-link.

Achuan pingche

I have to admit that Land Rover is the dream of many men. The "Land Rover" here may be a Range Rover, a defender or a discovery. However, under the pressure of the economy, they may not be able to touch such high-end and high-priced models, but there is still a kind of Land Rover that is more affordable to the people, such as the Discovery Sports Edition in the early 200,000 class, which is the second best choice for Land Rover fans. After all, it is also a land rover. (Text /Shen)

Biden has another big move!

On Thursday (August 15th) local time, Biden’s government announced that it had reached a "historic" agreement with pharmaceutical companies. According to the data released by the White House, the price reduction of the first 10 drugs included in the negotiations ranged from 38% to 79%. On the same day, US President Biden and Vice President Harris held their first joint activity since Biden withdrew from the 2024 election. Biden said at the event: "We finally beat the big pharmaceutical companies."

At the same time, another news related to Biden also attracted attention. According to a number of US media reports, a few days ago, hundreds of lawyers from all over the world jointly sent a letter to US President Biden, calling on the United States to stop using unilateral economic sanctions, saying that this tool is equivalent to collective punishment of civilians and violates international law.

In the joint letter, lawyers, legal organizations and scholars condemned the United States’ increasing reliance on sanctions to punish and intimidate its opponents, and said that these measures may lead to economic instability, hunger and the reduction of basic commodities such as medicines. The letter pointed out: "At present, hundreds of millions of people live under the extensive economic sanctions imposed by the United States in some form."

Biden’s government announced heavily

On Thursday (August 15th) local time, Biden’s government announced that it had reached a "historic" agreement with pharmaceutical companies, and the negotiated new drug price could save Medicare a net of about $6 billion by 2026. In addition, the new drug price will save the insured $1.5 billion in out-of-pocket expenses.

According to the data released by the White House, the price reduction of the first 10 drugs included in the negotiations ranged from 38% to 79%. Among them, the biggest drop was Merck’s hypoglycemic drug Januvia, whose price dropped from $527 to $113 in 30 days, while Novo Nordisk’s insulin injection pen Novo Horizo, whose monthly medication cost also dropped from $495 to $119.

According to media reports, this is part of a plan that Biden praised on Thursday, aimed at easing anger over high prices before the November election. The Inflation Reduction Act signed by Biden was signed into law in 2022, which was the first bill to allow medical insurance to negotiate the price of some of the most expensive drugs covering 66 million people in the plan.

On Thursday, US President Biden and Vice President Harris held their first joint activity since Biden withdrew from the 2024 election, and supported her to replace him on the Democratic ballot.

"We know that this is not only about health care, but also about your dignity," Biden said of the policy. "This is about inner peace. This is related to security. This is about taking care of your family. This is to give people more breathing space. " Biden said that they "just started" and that he and Harris "will continue to fight against big pharmaceutical companies". He said: "I played too hard. I can’t give in now. We won’t back down. “

Reuters said that although this was an official event, Biden turned his speech in the gymnasium into a de facto campaign rally, calling Harris a "hellish president" and criticizing Republicans for not supporting the right of medical insurance to negotiate drug pricing.

The Republican House leadership, including House Speaker Mike Johnson, described this power as "price manipulation" in a statement. Their prescription drug price manipulation plan only accomplished two things: pushing up the cost of health care and smashing American medical innovation.

Hundreds of lawyers signed a letter to Biden.

A few days ago, Bloomberg, CommonDreams and other media reported that dozens of legal organizations from all over the world, as well as more than 200 lawyers and scholars jointly sent a letter to US President Biden, urging the US government to end unilateral economic sanctions, saying that such sanctions constitute a collective punishment for civilians and are illegal under international law.

The signatories of this letter include human rights lawyers, American National Bar Association, European Lawyers Association for Democracy and World Human Rights, and law professors. The signer said in the letter: "Collective punishment is the standard practice of American foreign policy today, which takes the form of extensive unilateral economic and financial sanctions." So far, the United States has imposed more unilateral economic sanctions than any other country in the world. They pointed out that although the use of sanctions is different from conventional warfare, its collective impact on civilians may be equally indiscriminate, punitive and fatal.

The letter pointed out: "At present, hundreds of millions of people live under the extensive economic sanctions imposed by the United States in some form, including ordinary people in countries such as Cuba, Iran, North Korea, Syria and Venezuela. These measures may cause serious and extensive harm to civilians. Extensive economic sanctions may trigger and prolong the economic crisis, hinder access to basic commodities such as food, fuel and medicine, and increase poverty, hunger, disease and even mortality, especially for children. This situation in turn tends to promote large-scale immigration. "

According to the letter, the United States has imposed a severe economic embargo on Cuba for more than 60 years, which has adversely affected all economic sectors of the country and seriously restricted Cubans’ access to basic necessities such as food, fuel and medicine. In the past 32 years, United Nations Member States have overwhelmingly opposed the United States embargo against Cuba. Last year’s vote was 187-2, and only the United States and Israel were against it.

It is understood that after the victory of the Cuban revolution in 1959, the US government announced the breaking of diplomatic relations with Cuba in 1961 and began to impose a comprehensive embargo on Cuba in 1962. Since 1992, the United Nations General Assembly has passed resolutions with overwhelming votes for dozens of consecutive times, demanding that the United States end its economic and financial blockade and trade embargo against Cuba. Bruno Rodriguez Parrilla, Cuba’s foreign minister, once criticized the decades-long American trade embargo against Cuba as "endless" like a hurricane, which brought huge economic losses and humanitarian disasters to Cuba. The Cuban Ministry of Foreign Affairs also said that the United States has exerted extreme pressure on Cuba in recent years and strengthened its economic and financial blockade and trade embargo against Cuba, which is the root cause of the recent sharp increase in illegal immigration of Cubans to the United States; If the United States wants to stop the tide of illegal immigration, it must cancel the economic blockade that "makes life difficult for Cubans".

The signer said that according to the resolutions of the UN General Assembly and the UN Human Rights Council, unilateral sanctions are suspected of violating the UN Charter. They also cited the Fourth Geneva Convention, which held that collective punishment constituted a war crime. The signatory added: "As a member of the legal profession, we call on the United States to abide by the existing international law and stop using extensive unilateral coercive measures. Seventy-five years after the signing of the Geneva Conventions, collective punishment must end. "

American sanctions and the Middle East crisis

It is worth noting that the current Middle East crisis is also related to the US sanctions against Iran.

On November 7, last year, the White House issued a statement extending the national emergency against Iran in an executive order signed by the United States on November 14, 1979 for one year until November 14, 2024. This also means that the economic sanctions imposed by the United States on Iran continue to be extended.

On June 27th this year, the State Council issued a statement announcing sanctions against entities and ships involved in Iranian oil and petrochemical trade. Not only that, but the United States and the West are also looking for excuses to increase sanctions against Iran.

After the overall escalation of the Ukrainian crisis, the United States and Europe accused Iran of providing drones and missiles to Russia; The EU believes that there is Iranian support behind the Yemeni Houthi armed forces in the Red Sea region. According to this, the Council of the European Union announced in May this year to expand the scope of sanctions against Iran, involving drones and missiles.

According to public information, Iran is the second largest natural gas reserve country and the third largest oil reserve country in the world. However, after decades of sanctions, Iran’s economy and society have been completely hit. According to data released by the World Bank, nearly 10 million Iranians fell into poverty in the first decade of the 21st century. The loss of oil revenue has led to the continuous growth of Iranian government debt and state-owned enterprise debt. In addition, the United States and the West imposed a technical blockade on Iran through sanctions. United Nations human rights experts have issued a statement saying that US sanctions forced the Iranian people to extend the use of old vehicles with low fuel efficiency, while the United States also prevented other countries from providing air pollution control technology to Iran, which endangered the health of the Iranian people.

Recently, the situation in the Middle East has become tense again. On August 12th, local time, senior US officials said that Iran would launch a "major" attack on Israel "or within this week". On the same day, Iranian President Massoud Pezehiqiyan said in a telephone conversation with German Chancellor Angela Scholz that Iran believes that it has the right to respond to "aggressors" according to international rules. Petrezhiqiyan said that the Israeli government’s continued "genocide" in Gaza and "terrorist acts" in other countries violated international law and posed a serious challenge to regional security and global peace in West Asia.

Proofreading: Zhu Tianting

[car home Jiaxing Preferential Promotion Channel] At present, large-scale preferential activities are being carried out in Jiaxing area. The maximum discount amount reached 148,900 yuan, and the minimum starting price was only 313,900 yuan. If you are interested in this model, you may wish to click "Check the car price" in the quotation form to get a higher discount.

BMW i4 adopts a unique front face design, and the iconic kidney-shaped air intake grille is particularly eye-catching. The air intake grille is mainly closed design, which emphasizes its electric identity. The body lines are smooth, and the overall style is dynamic and futuristic, showing the high-end and sporty atmosphere of the BMW brand.

BMW i4 has elegant body lines, with a body size of 4785*1852*1455mm and a wheelbase of 2856mm, providing spacious and comfortable seating space for passengers. The front and rear wheel tracks are 1601mm and 1630mm respectively, which ensures the stability and handling of the vehicle. In addition, it is equipped with 245/45 R18 front tires and 255/45 R18 rear tires, and with dynamic rim design, it further enhances the sense of movement and driving experience of the vehicle.

The interior design of BMW i4 combines modern technology with luxurious texture. The center console is equipped with a 14.9-inch high-definition touch screen and the built-in iDrive 8.0 system, which supports voice recognition to control multimedia, navigation, telephone and air conditioning, greatly improving the driving experience. The steering wheel is made of high-grade leather, which provides manual up-and-down and forward-and-backward adjustment functions to ensure that the driver finds the best grip position. In addition, the car is equipped with a variety of multimedia and charging interfaces, including USB and Type-C interfaces, to meet the charging needs of different devices. In terms of seats, BMW i4 provides a variety of material choices, including imitation leather, genuine leather and leather /Alcantara mix and match. The main and auxiliary seats support multi-directional adjustment and heating functions, while the rear seats support proportional tilting, which improves the ride comfort and space flexibility.

The engine of BMW i4 has a strong output, with a maximum power of 210kW and a maximum torque of 400 Nm, which provides excellent acceleration performance and power performance for the vehicle.

It is said that the BMW i4 has excellent sound insulation effect, abundant power, and the design is very king-like, especially the volcanic red interior. He thinks that it is not even inferior to Mercedes-Benz’s sister.

　

　　　　On June 18th, seven MPV Ruifeng M3s officially landed in the Guangdong market, with a price of 69,800-74,800. As the first small MPV for makers in China, Ruifeng M3 accurately meets the needs of Guangdong Maker’s core vehicles, and is tailor-made for makers in terms of appearance, space and energy-saving kinetic energy. In Guangdong, a region with a strong entrepreneurial atmosphere, Ruifeng M3 will become the "dream partner" of the maker group and accelerate together with the maker.

　　　　Guangdong chose Ruifeng M3.

　　　　Guangdong has always been a strategic zone of China’s opening to the outside world, and it has a high-quality soil for economic development. This new maker economy has chosen Guangdong. Under the new opportunity of deep economic reform, Guangdong vigorously promotes entrepreneurial innovation, promotes the transformation and upgrading of industrial economy, and makes entrepreneurial innovation a "multiplier" for economic growth. Meanwhile, the two "Maker China" bases of the Information Center of the Ministry of Industry and Information Technology settled in Shunde and Zhuhai last month. Maker space, Maker community and alliance similar to firewood space have formed a certain scale gathering in Guangdong. There are tens of thousands of makers active in Shenzhen and Guangzhou, and many college students’ innovation and entrepreneurship competitions have kept the upsurge of grassroots entrepreneurship in Guangdong high.

　　　　In the face of the surge in demand for entrepreneurial vehicles, Guangdong Maker chose Ruifeng M3. As a well-prepared maker MPV, Ruifeng M3 has seriously considered the actual needs of pioneering and smart Guangdong makers, and carefully considered the appearance, space, power and economy, and every detail shows the maker attributes of Excellence and quality innovation. In Guangdong, an open and innovative province, Ruifeng M3 has also displayed the signboard of quality innovation: on the basis of inheriting 13 years of MPV manufacturing experience, Ruifeng M3 interprets the new trend of small MPV in a brand-new language, providing powerful entrepreneurial partners for Guangdong makers.

　　　　Large space, strong enough to save fuel.

　　　　Smart, hard-working, open and innovative, and influenced by the early reform and opening up economy, Guangdong people have shown these distinctive characteristics. Nowadays, in the face of the maker’s economic tide, the makers here still have such characteristics. The difference is that countless people who read cars need not only ordinary means of transportation, but also an entrepreneurial partner who can work hard together, meet customers and save money. Ruifeng M3 tailored for makers in terms of space, power and economy can meet the new standards of Guangdong makers.

　　　　Ruifeng M3 adopts three-stage front face design style, spread-wing chrome grille and blackened headlights, which inherits the appearance of Ruifeng MPV family genes and highlights the atmosphere of fashion and business. In space, the body size of Ruifeng M3 is 4,645 * 1,740 * 1,900 mm, with a wheelbase of 2810mm and 8 seats in various combinations, making it a mobile conference room, which is convenient for hard-working Guangdong makers to talk about business anytime and anywhere. At the same time, the cargo space of Ruifeng M3 reaches 4,450 L, which allows makers to pull goods and deliver goods correctly, and fully meets the diverse needs of business reception, pulling goods and delivering goods and family trips.

　　　　Facing the smart entrepreneurial style of Guangdong Chuangke, Ruifeng M3 can also give a good response. With a 1.6VVT lightweight all-aluminum engine and a mature 5MT gearbox, the fuel consumption of Ruifeng M3 is as low as 7.8L per 100 kilometers, less than 6 cents per kilometer. The lightweight design of the engine achieves high efficiency and fuel saving, and at the same time, the power and torque performance are also very strong. There is no need to worry about pulling goods uphill, which makes Guangdong Maker’s road to entrepreneurship full of power.

　　　　Editor’s comment:Where the maker is, Ruifeng M3 will go. In more than two months, Ruifeng M3 has successively landed in Suzhou, Yiwu, Chengdu and other maker gathering places. After this listing in Guangdong, Ruifeng M3 completed the market layout nationwide and took the lead in occupying the most advantageous stronghold in the maker economy era. With the ever-changing communication language of makers with great space and new energy-saving power, Ruifeng M3 can be said to have occupied the favorable climate, favorable geographical position and harmonious people, and it is just around the corner to create another legend of Ruifeng brand.

Related content review:

Flexible and changeable test drive in space Jianghuai Ruifeng M3 1.6 Manual

　　An assessment report released by Israel’s Ministry of Economy and Industry earlier this week shows that the new round of Palestinian-Israeli conflict has seriously impacted Israel’s national economy. Nearly one-fifth of the country’s labor force and the vast majority of Palestinians with work permits are out of work, resulting in economic losses of 13 billion new shekels (about 3.44 billion US dollars).

△ On November 15th, local time, Israeli air strikes were carried out in northern Gaza.

　　On October 7th, the Palestinian Islamic Resistance Movement (Hamas) launched a surprise attack on military and civilian targets in Israel from the Gaza Strip, and Israeli Prime Minister Benjamin Netanyahu declared the whole country into a "state of war" on the same day. Over the past month or so, Israeli military operations in the Gaza have killed more than 11,000 Palestinians and injured more than 28,000 others. About 1,200 people in Israel died in the conflict and more than 7,200 people were injured. Another 240 people were held hostage by armed groups in Gaza, such as Hamas. Hamas said that dozens of them were killed by Israeli air strikes.

　　According to the assessment report released by the Israeli Ministry of Economy and Industry on the 13th, about 764,000 domestic laborers have been out of work since the outbreak of this round of conflict, accounting for 19.4%. The main reasons for the absence of domestic labor force include being drafted into the Israeli army reserve, high risk in residential areas, and having to accompany their children at home because of the suspension of school. In response to the war, the Israeli government announced the mobilization of 360,000 reservists.

　　The report pointed out that after the conflict broke out, 97% of the approximately 135,000 Palestinian laborers working in Israel were not allowed to enter Israel at this stage, which led to the impact on many important industries such as construction, agriculture and service. Most of these Palestinian laborers come from the West Bank, and many from Gaza. The economic loss caused by the inability of Palestinian workers to be on duty is about 3 billion NIS (US$ 780 million), and the economic loss caused by the absence of all workers has reached 13 billion NIS.

△ November 14th, local time, a refugee camp in Gaza.

　　According to this report, due to the conflict, the demand for goods and services in Israel’s domestic market has declined, and household credit card spending has dropped by about 20% year-on-year.

　　According to data from Israel’s Central Bureau of Statistics, since the conflict broke out, more than half of Israeli enterprises have faced more than 50% turnover losses. In southern Israel, near the Gaza Strip, two-thirds of enterprises either closed down or operated minimally. In addition, the data shows that from October 8 to October 31, the number of foreign tourists arriving in Israel decreased by 73.1% compared with the same period of last year, and the number of people going abroad in Israel decreased by 45.1% year-on-year.

　　According to the report released by Israel Airport Authority on 14th, there are only seven foreign airlines flying to Israel. The passenger flow of Ben-Gurion International Airport, Israel’s largest airport, was 1.17 million in October, a decrease of 41.25% compared with the same period in 2022; There were 9078 international flights, down 28.9% year-on-year.

　　Israel’s National Security Institute estimates that since the outbreak of the conflict, the average daily expenditure of the Israeli government has been about 1 billion new shekels (about 260 million US dollars), and it is estimated that the total cost of Israel in this round of conflict will reach 150 billion to 200 billion new shekels, accounting for about 10% of GDP.